Climavision, which launched in 2021 with goal of closing observation and forecasting gaps, spoke to the commissioners about ...
NeoGenomics, Inc. recently showcased new assay data and highlighted its RaDaR ST molecular residual disease test at the European Society for Medical Oncology Congress 2025, presenting how this ...
NeoGenomics will present research at ISLB 2025 showing high concordance between its RaDaR ST and RaDaR 1.0 MRD assays, plus ...